Popular diabetes and weight-loss drug associated with lower opioid overdose risk

Case Western Reserve University School of Medicine identifies a potential new approach to address the opioid overdose epidemic—which has devastated families and communities nationally. Semaglutide was found to lower opioid overdoses in people with opioid-use disorder (OUD) and type 2 diabetes (T2D).

Improving release process and treatment after incarceration may reduce opioid overdoses.

New research from Tufts University School of Medicine suggests critical changes to the process of transitioning people out of jail while on substance use treatment can reduce opioid deaths among the highly susceptible population.